128 related articles for article (PubMed ID: 23582914)
1. Pathology - grading and staging of GEP-NETs.
Capelli P; Fassan M; Scarpa A
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):705-17. PubMed ID: 23582914
[TBL] [Abstract][Full Text] [Related]
2. High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective Analysis.
Hayes AR; Furnace M; Shah R; Rundell C; Muller G; Dehbi HM; Luong TV; Toumpanakis C; Caplin ME; Krell D; Thirlwell C; Mandair D
Pancreas; 2021 Apr; 50(4):516-523. PubMed ID: 33939663
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Characteristics of Gastroenteropancreatic Neuroendocrine Tumors: 10 Years of Experience From a Single Center.
Şentürk M; Acar B; Yildirim MA; Çakir M; Küçükkartallar T; Vatansev C
Pancreas; 2022 Feb; 51(2):159-163. PubMed ID: 35404891
[TBL] [Abstract][Full Text] [Related]
4. Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia.
Marasco M; Magi L; Rogges E; Dell'Unto E; Rinzivillo M; Pilozzi E; Annibale B; Panzuto F
Endocrine; 2023 Nov; 82(2):435-441. PubMed ID: 37338723
[TBL] [Abstract][Full Text] [Related]
5. The impact of surgery and survival prediction in patients with gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Wang W; Zhang K; Fan M; Lin R
Int J Surg; 2023 Jun; 109(6):1629-1638. PubMed ID: 37133986
[TBL] [Abstract][Full Text] [Related]
6. ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms.
Hallet J; Clarke CN
Ann Surg Oncol; 2024 Mar; 31(3):1704-1713. PubMed ID: 38167813
[TBL] [Abstract][Full Text] [Related]
7. Radioguided Surgery for Gastroenteropancreatic Neuroendocrine Tumours: a Systematic Literature Review.
Cockburn KC; Toumi Z; Mackie A; Julyan P
J Gastrointest Surg; 2021 Dec; 25(12):3244-3257. PubMed ID: 34506015
[TBL] [Abstract][Full Text] [Related]
8.
Herring B; Jang S; Whitt J; Goliwas K; Aburjania Z; Dudeja V; Ren B; Berry J; Bibb J; Frost A; Chen H; Rose JB; Jaskula-Sztul R
Front Endocrinol (Lausanne); 2021; 12():710009. PubMed ID: 35002949
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic metastasis from small bowel neuroendocrine tumor.
Addeo P; Fattori A; Imperiale A; Bachellier P
Dig Liver Dis; 2023 Oct; 55(10):1434-1435. PubMed ID: 37482522
[No Abstract] [Full Text] [Related]
10. ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.
Hicks RJ; Dromain C; de Herder WW; Costa FP; Deroose CM; Frilling A; Koumarianou A; Krenning EP; Raymond E; Bodei L; Sorbye H; Welin S; Wiedenmann B; Wild D; Howe JR; Yao J; O'Toole D; Sundin A; Prasad V
J Neuroendocrinol; 2022 Mar; 34(3):e13040. PubMed ID: 34668262
[TBL] [Abstract][Full Text] [Related]
11. Metastatic small-bowel neuroendocrine tumours: medical management of the primary.
Stålberg P
Br J Surg; 2023 Sep; 110(10):1296-1297. PubMed ID: 37527436
[No Abstract] [Full Text] [Related]
12. Can radiomics outperform pathology for tumor grading?
Ronot M; Soyer P
Diagn Interv Imaging; 2024 Jan; 105(1):3-4. PubMed ID: 37714731
[No Abstract] [Full Text] [Related]
13. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Pavel M; Öberg K; Falconi M; Krenning EP; Sundin A; Perren A; Berruti A;
Ann Oncol; 2020 Jul; 31(7):844-860. PubMed ID: 32272208
[No Abstract] [Full Text] [Related]
14. Approaching Small Neuroendocrine Tumors with Radiofrequency Ablation.
Rossi G; Petrone MC; Healey AJ; Arcidiacono PG
Diagnostics (Basel); 2023 Apr; 13(9):. PubMed ID: 37174952
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios.
Konstantinoff KS; Morani AC; Hope TA; Bhosale PR; Francis IR; Yano M; Iravani A; Trikalinos NA; Itani M
Abdom Radiol (NY); 2023 May; 48(5):1843-1853. PubMed ID: 36737523
[TBL] [Abstract][Full Text] [Related]
16. The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases.
Ramdhani K; Braat AJAT
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884479
[TBL] [Abstract][Full Text] [Related]
17. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Yin F; Wu ZH; Lai JP
World J Gastroenterol; 2022 May; 28(17):1751-1767. PubMed ID: 35633912
[TBL] [Abstract][Full Text] [Related]
18. Gastric neuroendocrine neoplasms: A review.
Köseoğlu H; Duzenli T; Sezikli M
World J Clin Cases; 2021 Sep; 9(27):7973-7985. PubMed ID: 34621854
[TBL] [Abstract][Full Text] [Related]
19. The overriding role of surgery and tumor grade for long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based cohort study.
Søreide JA; Kvaløy JT; Lea D; Sandvik OM; Al-Saiddi M; Haslerud TM; Garresori H; Karlsen LN; Gudlaugsson E; Søreide K
Cancer Rep (Hoboken); 2022 Feb; 5(2):e1462. PubMed ID: 34105314
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Immunostaining and Tumor Markers Predict the Prognosis of Esophageal Neuroendocrine Cell Carcinoma Patients.
Sohda M; Saeki H; Kuwano H; Miyazaki T; Yokobori T; Sano A; Sakai M; Kakeji Y; Toh Y; Doki Y; Matsubara H
Ann Surg Oncol; 2021 Nov; 28(12):7983-7989. PubMed ID: 33843025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
